Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide (Q37102996)
Jump to navigation
Jump to search
scientific article published on 24 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide |
scientific article published on 24 January 2009 |
Statements
1 reference
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide (English)
1 reference
Michel Komajda
1 reference
John Kjekshus
1 reference
John J V McMurray
1 reference
Jan H Cornel
1 reference
Peter Dunselman
1 reference
Ake Hjalmarson
1 reference
Timo Kuusi
1 reference
Johan Vanhaecke
1 reference
John Wikstrand
1 reference
Hans Wedel
1 reference
Magnus Lindberg
1 reference
John G F Cleland
1 reference
Finn Waagstein
1 reference
CORONA Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference